Lecture 11: COPD Flashcards

1
Q

COPD definition

A

Collection of conditions characterized by persistent expiratory airflow limitation that is not fully reversible associated w/ enhanced inflammatory response and exacerbations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Big FEV1 / FVC difference between COPD and asthma

A

Ratio cannot NORMALIZE even after administration of bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic bronchitis definition

A

Chronic, productive cough on most days for at least 3 months a year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic bronchitis pathology

A

Hypertrophy/hyperplasia of mucus glands, bronchial wall inflammation/fibrosis –> bronchial wall thickening (edema, BM thickening, increased SM) with decreased luminal size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Chronic bronchitis is a _________ dx; emphysema is a _________ dx

A

Clinical; pathological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe emphysema

A

Destruction of lung parenchyma and enlargement of air spaces distal to terminal bronchiole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of emphysema and description

A

Centrilobular (proximal acinar): predominantly involves respiraotry bronchiole and upper lungs, smokers; Panlobular (panacinar), lower lungs, see in alpha1-antitrypsin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does alpha-1 antitrypsin do?

A

Inhibitor of neutrophil elastase, which is a proteolytic enzyme that degrades elastin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does smoking involve the protease-antiprotease theory?

A

Inactivates alpha-1 antitrypsin and recruits neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Variants in alpha-1 antitrypsin disease and which is more dangerous and which is more common

A

Z-variant (more dangerous) and S-variant (more common)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Z-variant

A

Failure to form alpha-1 antitrypsin salt bridge leading to slowly folding protein that form globules that are never secreted and accumulate hepatocytes (cirrhosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

S-variant

A

Renders alpha-1 antitrypsin more susceptible to proteolysis; not associated with intracellular accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Emphysema: lung compliance increased or decreased

A

Increased!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the equal pressure point?

A

Point at which the pressure within the bronchus and within the chest cavity are equal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is there decreased trans pulmonary pressure in emphysema?

A

Because the lungs are more compliant (less stiff), they cannot withstand a strong pressure differential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why does a decreased trans pulmonary pressure impact emphysema?

A

You reach the EPP earlier, meaning that on expiration, there is obstruction

17
Q

What does decreased airway tethering mean?

A

Fewer “tethers” of the airways mean they cannot be open fully (decreased diameter)

18
Q

FRC and TLC in ephysema. What about VC?

A

FRC is larger because of increased compliance, TLC is increased (hyperinflation); VC is reduced

19
Q

Mechanical disadvantage in ephysema

A

Enlarged lungs –> flattened diaphragm –> less strength of diaphragm (dyspnea)

20
Q

Describe dynamic hyperinflation in a patient with COPD during exercise

A

They struggle with breathing out, meaning less time to breath out, so their end expiratory lung volume INCREASES as minute vent increases

21
Q

V/Q in chronic bronchitis

A

Problem with airway leads to V/Q mismatch

22
Q

V/Q in emphysema

A

Destroyed whole unit (alveolus and capillary), so may not get hypoxemia

23
Q

Alveolar hypoventilation in emphysema

A

Increased work of breathing –> decreased central ventilatory drive AND increased dead space due to tissue destruction (this area is ventilated but not perfused = V/Q mismatch)

24
Q

Symptoms of COPD

A

Dyspnea, cough (w/ sputum), exacerbations

25
What precipitates an exacerbation?
Viral infections, pollution, bronchospasm
26
Exam findings with emphysema
Prolonged expiratory phase, decreased breath sounds, wheezing (expiratory), ronchi
27
Exam findings with severe emphysema/COPD
Barrel-shaped chest, purse-lipped breathing (increases pressure in airways to stent open airways), emaciation
28
How can you see emphysema on X-ray/CT?
Hyperinflation by counting ribs and "moth eaten" appearance on CT
29
Causes of pulmonary HT in COPD
Hypoxia and other vessel changes, thromboembolism, parenchymal destruction (decreased vessels), LV dysfunction, hyperinflation
30
Chronic bronchitis and smoking (3 histological changes)
Mucus hypertrophy and hyperplasia, broncial wall inflammation, impaired mucociliary clearance
31
Chronic emphysema and smoking (2 histological changes)
Increased number of neutrophils --> increased elastase, oxidation of alpha-1 antitrypsin --> decreased function
32
What are other risk factors for emphysema?
Occupational exposures and indoor air pollution (cooking with biomass fuels)
33
Blue bloater
Chronic bronchitis: overweight, cyanotic, elevated Hb, peripheral edema, ronchi and wheezing
34
Pink puffer
Emphysema: older and thin, severe dyspnea, quiet chest, xray: hyperinflation with flattened diaphragm
35
What is the diagnostic requirement for COPD?
Airflow obstruction: you can have ephysema and chronic bronchitis without COPD
36
How is COPD a systemic disease?
SYSTEMIC inflammation related to ischemic HD, osteoporosis, metabolic syndrome, depression via systemic inflammation
37
Emphysema tx
Proven survival benefit: smoking cessation and supplemental O2 for hypoxemic pts
38
Emphysema sx management
Inhaled bronchodilators and corticosteroids
39
Describe lung volume reduction surgery
Reduces lung volume to reduce physiologic dead-space, increases elastic recoil, improve mechanic functioning of diaphragm